Charles River Laboratories (CRL) Tops Q1 EPS by 8c; Boosts Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Charles River Labs (CRL) Number Cut at Jefferies on Slower Start; 'Buy' Maintained
May 1, 2014 10:46 AM EDTJefferies analyst David Windley lowered estimates and his price target on Buy-rated Charles River Labs (NYSE: CRL) to $66.00 (from $73.00) following Q1 results which showed a slower start to the year.
Windley comments, "CRL's results met internal expectations, but they fell shy of ours.... More
